Cancer cells rely on glutathione as fuel for growth
View as a Web Page
News Medical
 
  Breast Cancer Breast Cancer logo  
  The latest breast cancer news from News Medical  
 AI model achieves 99.24 % accuracy in breast ultrasound classificationAI model achieves 99.24 % accuracy in breast ultrasound classification
 
This study presents a deep learning model for breast cancer detection, achieving 99.24% accuracy and improving clinical decision-making through image retrieval.
 
 
 Cancer cells rely on glutathione as fuel for growthCancer cells rely on glutathione as fuel for growth
 
Researchers discovered an antioxidant, glutathione, that cancer cells appear to be "addicted to" as fuel, opening new pathways for investigation and a potential drug that can restrict the way tumors use this nutrient.
 
   Exercise cuts 'chemo brain' and fatigue in cancer patientsExercise cuts 'chemo brain' and fatigue in cancer patients
 
Implementing a simple exercise plan during chemotherapy may ease cognitive impairment and fatigue, promoting better health outcomes for cancer patients.
 
   Study: Women survive cancer more but face higher treatment toxicityStudy: Women survive cancer more but face higher treatment toxicity
 
Women are more likely to survive cancer than men but face a higher risk of serious and adverse side effects from treatment, according to a landmark international study from Adelaide University.
 
   Blood-based test helps personalize breast cancer care for older patientsBlood-based test helps personalize breast cancer care for older patients
 
For women age 70 and over with a common form of breast cancer, determining "the right size" of treatment can be challenging, in part because clinicians have limited tools to guide individualized treatment decisions.
 
 Why are men missing cancer tests despite higher positive rates?
 
Why are men missing cancer tests despite higher positive rates?A study highlights a gap in cancer prevention, showing men undergo genetic testing less often yet are more likely to carry high-risk cancer variants.
 
 
 Combination therapy shows promise for leptomeningeal metastasis in breast cancer
 
Combination therapy shows promise for leptomeningeal metastasis in breast cancerPatients with leptomeningeal metastasis (LM) have historically had few treatment options. Now, researchers from The University of Texas MD Anderson Cancer Center have found a combination of targeted therapies, tucatinib and trastuzumab, plus the chemotherapy drug, capecitabine, may improve symptoms and extend survival in some breast cancer patients with LM.
 
 
 Researchers develop targeted delivery system for poorly soluble cancer drugs
 
Researchers develop targeted delivery system for poorly soluble cancer drugsRecent advances in drug discovery research have led to the development of numerous drug candidate compounds with high therapeutic efficacy.
 
 
 Reducing lung cell lipid production decreases metastatic tumor spread
 
Reducing lung cell lipid production decreases metastatic tumor spreadScientists from the VIB–KU Leuven Center for Cancer Biology, in collaboration with the Francis Crick Institute, have discovered how cancer cells can exploit healthy lung cells to support metastatic tumor growth in the lungs.
 
 
 Solving a 50-year bottleneck in chemotherapy drug production
 
Solving a 50-year bottleneck in chemotherapy drug productionA multinational team of researchers has made a significant advance in the manufacturing of doxorubicin, a crucial chemotherapy drug.
 
 
 Metasurface AI breakthrough brings faster medical imaging
 
Metasurface AI breakthrough brings faster medical imagingA new hybrid optical-digital AI system uses a massive fixed metasurface and a tiny trainable backend to match top digital models across vision tasks, while delivering striking speed gains in demanding applications such as cancer slide analysis.
 
 
 Engineered bacteria deliver targeted anticancer therapy in tumors
 
Engineered bacteria deliver targeted anticancer therapy in tumorsEvery year, millions of people are diagnosed with cancer globally; however, current treatments are limited by disease complexity.
 
 
 Cancers use lipids produced by lung cells to support metastatic tumor growth
 
Cancers use lipids produced by lung cells to support metastatic tumor growthScientists from the VIB–KU Leuven Center for Cancer Biology, in collaboration with the Francis Crick Institute, have discovered how cancer cells can exploit healthy lung cells to support metastatic tumor growth in the lungs.
 
Facebook X Instagram LinkedIn Vimeo
Why did you receive this email?
You are receiving this email because you subscribed to updates from AZoNetwork UK Ltd. on one of our websites and requested to be notified of additional information.

Unsubscribe or Update Notification Preferences

Contact | About | Privacy Policy

- - - - - -

Registered Address:
AZoNetwork UK Ltd., NEO, 9 Charlotte St, Manchester, M1 4ET, UK

Manchester | Sydney | Boston

Copyright © 2000-2026